Jinxia Wei

Dr. Jinxia Wei


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 May 2022 in Frontiers in Chemistry
Verified
Journal Article
Open access
JWJinxia Wei
Jinxia Wei
YYYingying Yu
Yingying Yu
YZYue Zhang
Yue Zhang
LLLingzhi Li
Lingzhi Li
XLXia Li
Xia Li
YLYubo Li
Yubo Li
Background: Myocardial ischemia (MI) is a leading cause of death worldwide. Menispermi Rhizoma is a traditional Chinese medicine that exerts a variety of beneficial pharmacological activities in many diseases, including MI.Purpose: Serum pharmacochemistry and network pharmacology were used to explore the material basis and mechanism of action of Menispermi Rhizoma against MI.Methods: The absorbed components of Menispermi Rhizoma in rat plasma were analyzed by ultra-performance liquid chromatography quadrupole time-of-flight tandem mass spectrometry (UPLC-Q-TOF/MS). The key components, targets, pathways, and interrelated information were obtained by network pharmacology. The potential effective components of Menispermi Rhizoma against MI were screened by methyl-thiazolyl-tetrazolium (MTT) assay, and the cardioprotective effect and mechanism of active components were verified by Western blotting and molecular docking.Results: In total, 25 absorbed components of Menispermi Rhizoma in plasma were identified. Network pharmacology revealed 81 major targets of Menispermi Rhizoma against MI, mainly involving the regulation of the PI3K/AKT and MAPK pathways. In vitro validation of H9c2 cells revealed that acutumine, daurisoline, dauricoside, and 6-O-demethylmenisporphine are the main bioactive components of Menispermi Rhizoma. The levels of lactate dehydrogenase, creatine kinase, and malondialdehyde (MDA) were significantly decreased by four alkaloids, whereas the activities of superoxide dismutase (SOD) and glutathione (GSH) were significantly increased. Four alkaloids effectively protected H9c2 cells against OGD-induced apoptosis by Hoechst/PI staining and flow cytometry assay. Western blotting results showed that the four alkaloids upregulated the expression ratio of Bcl-2/Bax and downregulated the expression levels of Cyt-C and cleaved caspase 3, which further supported the anti-cardiomyocyte apoptosis and antioxidative stress effect of Menispermi Rhizoma. Molecular docking confirmed that the four compounds were capable of binding to AKT1, MAPK1, EGFR, CASP3, and MAPK8 proteins, suggesting the protective effect of Menispermi Rhizoma on MI via PI3K/AKT, MAPK, and apoptosis pathways.Conclusion: Menispermi Rhizoma exerted cardioprotective effects through the effect characteristics: multiple-ingredient, multi-target, and multi-pathway. This research provided a reference for further mechanistic research on wider applications of Menispermi Rhizoma for MI treatment.

4 January 2021 in Journal of Analytical Science and Technology
Verified
Journal Article
Open access
PDF file
JWJinxia Wei
Jinxia Wei
JSJia Shao
Jia Shao
YLYanan Li
Yanan Li
YLYubo Li
Yubo Li
Background: To investigate the pharmacokinetics of 6-O-demethylmenisporphine, an oxoisoaporphine alkaloid with significant anti-tumor activities and isolated from Menispermi Rhizoma, a novel and sensitive HPLC assay was established for 6-O-demethylmenisporphine quantification in rat plasma. Methods: Peak responses were detected by a highly selective and sensitive fluorescence detector with 426-nm excitation and 514-nm emission wavelengths. Curcumin was employed as the internal standard (IS). A Capcell Pak C18 column (150 mm × 4.6 mm i.d., 5 μm) and an isocratic elution procedure with a flow rate of 1.0 mL/min were used to exclude the endogenous interfering substance. Acetonitrile-water (68:32, v/v) containing 1% formic acid was employed as mobile phase. A 7-point calibration curve that covered the concentration range of 10–2500 ng/mL was constructed. Results: A good linearity was observed with a correlation coefficient (r) of 0.9993. The lower limit of quantification for 6-O-demethylmenisporphine was 10 ng/mL. The mean recoveries of analyte in rat plasma exceeded 80.5%. The precision at four concentration levels was within 11.3% and the accuracy ranged from − 7.6 to 6.7%. Conclusion: Using this new HPLC-FLD method, the investigation of plasma samples from rats following oral dosing of neat compound and Menispermi Rhizoma extract was successfully conducted. The results will provide a reference for the evaluation of preclinical safety of 6-O-demethylmenisporphine.

24 April 2017 in Analytical Methods
Verified
Journal Article
Closed access
PDF file
JWJinxia Wei
Jinxia Wei
KCKunna Cui
Kunna Cui
YDYueying Du
Yueying Du
JYJia Yu
Jia Yu
ZJZhen Jiang
Zhen Jiang
XGXingjie Guo
Xingjie Guo
A multi-component-assay quality control method, using ultra-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry, has been developed for the simultaneous quantification of 22 constituents in Menispermi Rhizoma. By employing a Waters BEH C18 column (50 mm × 2.1 mm, i.d., 1.7 μm), 22 constituents were separated within only 14 min using a gradient elution system consisting of acetonitrile and 0.1% aqueous formic acid at a flow rate of 0.3 mL min−1. Mass spectrometric detection was performed using multiple reaction monitoring mode via an electrospray ionization source operating in positive ionization mode. The validation of the method, including linearity, sensitivity, precision, accuracy and stability, was carried out and demonstrated to satisfy the requirements of quantitative analysis. The developed method was successfully applied for the simultaneous quantification of 22 components in 10 batches of Menispermi Rhizoma obtained from different regions of northern China, and the results showed that the contents of analytes in Menispermi Rhizoma from different sources varied widely. Hierarchical cluster analysis was performed to differentiate and classify the samples based on the contents of the 22 characteristic constituents, which is helpful for the comprehensive evaluation of the quality of Menispermi Rhizoma.

4 March 2025 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Closed access
LSLili Song
Lili Song
JLJiayi Lin
Jiayi Lin
WYWeiyu Yang
Weiyu Yang
LZLijuan Zhang
Lijuan Zhang
HLHuimin Liu
Huimin Liu
YLYubo Li
Yubo Li

3 October 2024 in Food Science and Biotechnology
Verified
Journal Article
Closed access
PDF file
XLXia Li
Xia Li
SLSijia Liu
Sijia Liu
FWFang Wang
Fang Wang
XLXinyue Li
Xinyue Li
HLHuiru Liu
Huiru Liu
TCTing Cai
Ting Cai

9 August 2022 in Frontiers in Chemistry
Verified
Journal Article
Open access
YWYuming Wang
Yuming Wang
XLXiaokai Li
Xiaokai Li
KGKun Gu
Kun Gu
JGJing Gou
Jing Gou
XLXue Li
Xue Li
YLYubo Li
Yubo Li
In recent years, the incidence of coronary heart disease and rheumatoid arthritis has been increasing, which has become a common public health problem worldwide. YiYiFuZi (YYFZ ) powder is a classical traditional Chinese prescription, which is commonly used to treat metabolic diseases such as rheumatoid arthritis, with an ideal curative effect, but the therapeutic mechanism is still unclear. In this study, from the perspective of clinical metabolomics, combined with network pharmacology, we sought the comorbidity mechanism and key targets of coronary heart disease and rheumatoid arthritis and the mechanism by which YYFZ powder exerts therapeutic effects, combined with molecular docking and atomic force microscopy to determine the effective components, and found that the higenamine and steroid components in YYFZ powder can bind acid sphingomyelinase enzymes to affect the sphingolipid pathway to produce therapeutic effects, which can bind to sugars existing as a glycoside.